Literature DB >> 3113196

Quantitative determination of MS-induced corpus callosum atrophy in vivo using MR imaging.

J H Simon, R B Schiffer, R A Rudick, R M Herndon.   

Abstract

To quantitate the extent of corpus callosum atrophy in multiple sclerosis, midsagittal corpus callosum areas were determined in 48 controls with normal MR scans and 41 patients with definite multiple sclerosis. The mean midsagittal corpus callosum area was 601 mm2 (range 405-791), 641 mm2, and 561 mm2 for all adult controls, for adult males, and for adult females, respectively. Control values were significantly greater than the means determined for all multiple sclerosis (MS) patients (508 mm2, range 281-758), for MS men (528 mm2), or for MS women (498 mm2). The degree of corpus callosum atrophy paralleled the estimated volume of periventricular and corpus callosum high-signal lesions, suggesting a possible cause-effect relationship. The results indicate that corpus callosum atrophy occurs commonly in patients with typical clinical forms of multiple sclerosis.

Entities:  

Mesh:

Year:  1987        PMID: 3113196      PMCID: PMC8333673     

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  9 in total

1.  Diffusion tensor group tractography of the corpus callosum in clinically isolated syndrome.

Authors:  F Lin; C Yu; Y Liu; K Li; H Lei
Journal:  AJNR Am J Neuroradiol       Date:  2010-10-21       Impact factor: 3.825

2.  Functional and magnetic resonance imaging correlates of corpus callosum in normal pressure hydrocephalus before and after shunting.

Authors:  Maria Mataró; Mar Matarín; Maria Antonia Poca; Roser Pueyo; Juan Sahuquillo; Maite Barrios; Carme Junqué
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-10-20       Impact factor: 10.154

3.  Functional correlates of callosal atrophy in relapsing-remitting multiple sclerosis patients. A preliminary MRI study.

Authors:  F J Barkhof; M Elton; J Lindeboom; M W Tas; W F Schmidt; O R Hommes; C H Polman; A Kok; J Valk
Journal:  J Neurol       Date:  1998-03       Impact factor: 4.849

Review 4.  Magnetic resonance imaging of multiple sclerosis lesions. Measuring outcome in treatment trials.

Authors:  J H Simon
Journal:  West J Med       Date:  1996-06

5.  MR imaging of the corpus callosum in pediatric patients with neurofibromatosis type 1.

Authors:  E C Dubovsky; T N Booth; G Vezina; C A Samango-Sprouse; K M Palmer; C O Brasseux
Journal:  AJNR Am J Neuroradiol       Date:  2001-01       Impact factor: 3.825

6.  Three dimensional MRI estimates of brain and spinal cord atrophy in multiple sclerosis.

Authors:  C Liu; S Edwards; Q Gong; N Roberts; L D Blumhardt
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-03       Impact factor: 10.154

7.  Impaired small-world efficiency in structural cortical networks in multiple sclerosis associated with white matter lesion load.

Authors:  Yong He; Alain Dagher; Zhang Chen; Arnaud Charil; Alex Zijdenbos; Keith Worsley; Alan Evans
Journal:  Brain       Date:  2009-12       Impact factor: 13.501

8.  Multiple sclerosis and corpus callosum atrophy: relationship of MRI findings to clinical data.

Authors:  J L Dietemann; C Beigelman; L Rumbach; M Vouge; T Tajahmady; C Faubert; M Y Jeung; A Wackenheim
Journal:  Neuroradiology       Date:  1988       Impact factor: 2.804

Review 9.  Clinical correlates of grey matter pathology in multiple sclerosis.

Authors:  Dana Horakova; Tomas Kalincik; Jana Blahova Dusankova; Ondrej Dolezal
Journal:  BMC Neurol       Date:  2012-03-07       Impact factor: 2.474

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.